XNPT 7.95 Xenoport Inc $XNPT Hit a 52 week high of 7.95

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
XNPT 7.95 Xenoport Inc $XNPT Hit a 52 week high of 7.95 Closing the day 09:45 at 7.95 +0.08 +1.02% With a day low of 7.87 and a total volume of 63,327.

XNPT Recent Posts: http://investorshangout.com/XenoPort-Inc-XNPT-55935/

XNPT Xenoport Inc Recent Headline News

52.4% Return Seen to Date on SmarTrend XenoPort Call (XNPT)
Comtex SmarTrend(R) - Wed Nov 12, 4:49PM CST
SmarTrend identified an Uptrend for XenoPort (NASDAQ:XNPT) on August 26th, 2014 at $5.17. In approximately 3 months, XenoPort has returned 52.37% as of today's recent price of $7.87.
XNPT: 8.08 (+0.21)

XenoPort's (XNPT) CEO Ron Barrett Presents at Credit Suisse Healthcare Conference (Transcript)
SA Transcripts - at Seeking Alpha - Wed Nov 12, 2:03PM CST

XNPT: 8.08 (+0.21)

Can the Uptrend Continue for XenoPort (XNPT)? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 6:33AM CST
Can the Uptrend Continue for XenoPort (XNPT)?
XNPT: 8.08 (+0.21)

XenoPort to Present at the Credit Suisse Healthcare Conference
Business Wire - Thu Nov 06, 12:09PM CST
XenoPort, Inc. (Nasdaq:XNPT) announced today that it will provide access via the World Wide Web to its presentation at the 2014 Credit Suisse Healthcare Conference in Phoenix, Arizona. The live presentation will occur at 8:30 a.m. Pacific Time (9:30 a.m. Mountain Time) on Wednesday, November 12, 2014. A replay of the presentation will also be available.
XNPT: 8.08 (+0.21)

XenoPort Has Returned 39.6% Since SmarTrend Recommendation (XNPT)
Comtex SmarTrend(R) - Wed Nov 05, 11:04AM CST
SmarTrend identified an Uptrend for XenoPort (NASDAQ:XNPT) on August 26th, 2014 at $5.17. In approximately 2 months, XenoPort has returned 39.59% as of today's recent price of $7.21.
XNPT: 8.08 (+0.21)

XenoPort's (XNPT) CEO Ron Barrett on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Nov 04, 9:40PM CST

XNPT: 8.08 (+0.21)

XenoPort (XNPT) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Tue Nov 04, 3:55PM CST

XNPT: 8.08 (+0.21)

XenoPort beats by $0.49, beats on revenue
Seeking Alpha - at Seeking Alpha - Tue Nov 04, 3:27PM CST

XNPT: 8.08 (+0.21)

XenoPort Reports Third Quarter Financial Results
Business Wire - Tue Nov 04, 3:07PM CST
XenoPort, Inc. (Nasdaq: XNPT) announced today financial results for the third quarter and nine months ended September 30, 2014. Revenues for the third quarter were $31.1 million compared to $2.5 million for the same period in 2013. Revenues for the third quarter included $25.0 million in collaboration revenue resulting from XenoPort's license agreement with Reckitt Benckiser Pharmaceuticals, Inc. Net income for the third quarter was $8.3 million compared to a net loss of $18.8 million for the same period in 2013. At September 30, 2014, XenoPort had cash, cash equivalents and short-term investments of $113.4 million.
XNPT: 8.08 (+0.21)

XNPT, AMRS, GSAT, CRDC, IOSP, OKS Expected To Be Down After Next Earnings Releases
M2 - Mon Nov 03, 3:33AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Tuesday, November 4th 2014 and determining how the stocks have performed After their last 12 quarterly, 6 quarterly and December earnings reports. Xenoport Inc (NASDAQ:XNPT), AMYRIS INC (NASDAQ:AMRS), Globalstar Inc (OTC:GSAT), Cardica Inc (NASDAQ:CRDC), INNOSPEC INC. (NASDAQ:IOSP), ONEOK PARTNERS, L.P. (NYSE:OKS) are all expected to be Down After their earnings are released. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go Down After earnings are released Tuesday:
AMRS: 2.82 (-0.11), IOSP: 43.80 (-0.43), OKE: 55.42 (-1.04), CRDC: 0.85 (-0.02), OKS: 47.99 (+0.01), GSAT: 2.81 (+0.06), XNPT: 8.08 (+0.21)

XenoPort Up 32.4% Since SmarTrend Uptrend Call (XNPT)
Comtex SmarTrend(R) - Wed Oct 29, 9:38AM CDT
SmarTrend identified an Uptrend for XenoPort (NASDAQ:XNPT) on August 26th, 2014 at $5.17. In approximately 2 months, XenoPort has returned 32.43% as of today's recent price of $6.84.
XNPT: 8.08 (+0.21)

XenoPort reports November 4
Seeking Alpha - at Seeking Alpha - Thu Oct 23, 10:53AM CDT

XNPT: 8.08 (+0.21)

XenoPort to Release Third Quarter Financial Results on November 4
Business Wire - Thu Oct 23, 9:00AM CDT
XenoPort, Inc. (Nasdaq:XNPT) announced today that it will release its third quarter financial results on November 4, 2014 at approximately 4:30 p.m. Eastern Time. The company will host a conference call at 5:00 p.m. Eastern Time that same day to provide a summary of its financial results and general business updates. A replay of the call will be available for one week following the event.
XNPT: 8.08 (+0.21)

XenoPort Shares Up 22.6% Since SmarTrend's Buy Recommendation (XNPT)
Comtex SmarTrend(R) - Wed Oct 22, 9:18AM CDT
SmarTrend identified an Uptrend for XenoPort (NASDAQ:XNPT) on August 26th, 2014 at $5.17. In approximately 2 months, XenoPort has returned 22.56% as of today's recent price of $6.33.
XNPT: 8.08 (+0.21)

Uptrend Call Working As XenoPort Stock Rises 20.2% (XNPT)
Comtex SmarTrend(R) - Tue Oct 14, 5:17PM CDT
SmarTrend identified an Uptrend for XenoPort (NASDAQ:XNPT) on August 26th, 2014 at $5.17. In approximately 2 months, XenoPort has returned 20.23% as of today's recent price of $6.21.
XNPT: 8.08 (+0.21)

Commit To Buy XenoPort At $5, Earn 15.8% Annualized Using Options
StockOptionsChannel.com - Thu Oct 09, 10:29AM CDT
Investors eyeing a purchase of XenoPort Inc shares, but tentative about paying the going market price of $5.82/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in...
XNPT: 8.08 (+0.21)

Anacor Pharmaceuticals Appoints Wendell Wierenga to Its Board of Directors
Business Wire - Fri Sep 12, 7:30AM CDT
Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) today announced that its Board of Directors has appointed Wendell Wierenga, Ph.D. to serve as a Class III director until the Company's 2016 annual meeting of shareholders. Anacor also announced that Paul Klingenstein has resigned from the Board.
CYTK: 4.30 (-0.06), SNTS: (), OCRX: 5.59 (-0.01), ANAC: 31.52 (-0.25), XNPT: 8.08 (+0.21)

Xenoport/NIAAA Collaborate on Alcoholism Therapy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Sep 10, 3:55PM CDT
Xenoport, Inc. (XNPT) entered into a clinical trial collaboration agreement with the National Institute on Alcohol Abuse and Alcoholism, for a study that will evaluate HORIZANT as a potential treatment for alcohol use disorder (AUD).
CBPO: 66.55 (-2.18), CBM: 23.26 (-0.76), AMGN: 160.15 (-1.78), XNPT: 8.08 (+0.21)

XenoPort to Present Data for Novel Fumarate Analog XP23829 at the 2014 Joint ACTRIMS-ECTRIMS Meeting in Boston
Business Wire - Wed Sep 10, 7:30AM CDT
XenoPort, Inc. (Nasdaq:XNPT) announced today that it will present data on XP23829, an investigational prodrug of monomethyl fumarate (MMF), at the 2014 Joint ACTRIMS-ECTRIMS Meeting in Boston. Data being presented include the results from a clinical trial evaluating the safety, tolerability and pharmacokinetics of XP23829.
XNPT: 8.08 (+0.21)

XenoPort and the NIAAA Announce Clinical Trial Agreement to Study HORIZANT as a Potential Treatment for Alcohol Use Disorder
Business Wire - Tue Sep 09, 7:30AM CDT
XenoPort, Inc. (Nasdaq:XNPT) and the National Institute on Alcohol Abuse and Alcoholism (NIAAA) announced today that they have entered into an agreement to conduct a clinical trial of HORIZANT(R) (gabapentin enacarbil) Extended-Release Tablets as a potential treatment for alcohol use disorder (AUD). Under the terms of the agreement, XenoPort will supply clinical trial material and the NIAAA will conduct and pay all other expenses associated with the proposed clinical trial of HORIZANT. XenoPort will have access to study results generated under the proposed clinical trial to support potential regulatory filings for HORIZANT.
XNPT: 8.08 (+0.21)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 126

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 607

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
Cardiovalve's Three-Year Data Clears a Crucial EU Hurdle

Updated Category News Views 98

A failing tricuspid valve is not a spreadsheet problem, and that matters before anybody gets carried away with a glossy conference presentation. Venus Medtech's Cardiovalve unit has reported results from TARGET in a population that was old, sick and largely out of good surgical options. That is precisely where a less invasive replacement therapy has to prove it can do...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 731

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
UAE Ties Diplomacy, Media and AI Into a Shared Signal

Updated Category News Views 128

Influence is getting harder to measure, and easier to squander, which is why the message from Ajman deserves more than a polite nod. At the 2026 Ajman Media Forum, THE SIGNAL, Foreign Affairs Undersecretary Omar Obaid Alhesan Alshamsi made the UAE’s position plain: diplomacy and media are no longer separate lanes. Both operate on words, context, trust and the difficult...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 534

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 385

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 666

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
DataBeyond Puts AI Sorting Before a Waste Mountain

Updated Category News Views 191

Trash is a lousy place to look for technological glamour, which is precisely why DataBeyond's COP31 appearance deserves a sober look. On November 19 in Antalya, Türkiye, the Hangzhou-based equipment provider used a China Pavilion event to lay out its case for AI, optical sensing and robots in resource recovery. That is not a magic-green headline. It is a practical...

Continue Reading
Build-A-Bear Lawsuit Notice Carries a Date Problem

Updated Category News Views 26

Something is badly out of sequence in the Build-A-Bear shareholder alert, and that matters before anybody gets carried away by the legal boilerplate. The notice says investors who bought NYSE: BBW securities from March 28, 2026 through August 26, 2026 may be covered by a proposed federal securities class action. It also says the lead-plaintiff deadline is January 19,...

Continue Reading

Top 5 Most Recently Viewed Articles

NuCana Discontinues Phase 2 Colorectal Cancer Study

Updated Category News Views 146

NuCana Provides Update on Phase 2 Randomized Colorectal Cancer Study NuTide:323 Study Discontinued Following Initial Analysis Ongoing Studies Show Promise with NUC-7738 and Pembrolizumab NuCana plc (NASDAQ: NCNA) has shared important updates about its clinical trials focused on innovative treatments for colorectal cancer. The company has made the decision to discontinue...

Continue Reading
Brøndbyernes IF Football Meeting - Key Highlights Recap

Updated Category News Views 179

Overview of the Annual General Meeting for Brøndbyernes IF Football A/S BRØNDBYERNES I.F. FODBOLD A/S CVR-nr. 83 93 34 10 This report summarizes the outcomes of the annual general meeting conducted by Brøndbyernes IF Football A/S. Key Date and Location The annual shareholders meeting took place, gathering stakeholders and shareholders at the club's headquarters. A...

Continue Reading
Uncovering the Wealth from Investing in BlackRock

Updated Category News Views 314

The Potential Growth of $1000 in BlackRock Investors often wonder how their money would grow over time if invested in strong companies. Recently, we looked into BlackRock, Inc., known by its stock ticker BLK. Over a span of 15 years, investing just $1000 into BlackRock stocks would yield an impressive value today. According to current evaluations, if you had made that...

Continue Reading
Zealand Pharma Advances Glepaglutide Approval for SBS Treatment

Updated Category News Views 267

Glepaglutide Submission to EMA Marks Significant Progress Zealand Pharma A/S, a pioneering biotechnology company, has recently shared exciting news about its Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for its innovative drug, glepaglutide. This long-acting GLP-2 analog is specifically designed for treating adults suffering from short...

Continue Reading
Seven Gables Real Estate Partners with Local Logic for Insights

Updated Category News Views 40

Seven Gables Real Estate Partners with Local Logic In a significant move that underscores their dedication to innovation, Seven Gables Real Estate has announced an exciting partnership with Local Logic, a leader in location intelligence. This collaboration is set to incorporate Local Logic's cutting-edge products—Local Content, Local Search, and NeighborhoodWrap—into...

Continue Reading